ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Reclaims Global Ltd
SGX:NEX
|
SG |
|
C
|
Cognor Holding SA
WSE:COG
|
PL |
|
C
|
Century Synthetic Fiber Corp
VN:STK
|
VN |
|
Rosseti Lenenergo PAO
MOEX:LSNG
|
RU |
|
A
|
Ampd Ventures Inc
CNSX:AMPD
|
CA |
|
TXNM Energy Inc
NYSE:TXNM
|
US |
|
I
|
Impala Platinum Holdings Ltd
SWB:IPHB
|
ZA |
|
C
|
CoStar Group Inc
XMUN:RLG
|
US |
|
Excelsior Mining Corp
TSX:MIN
|
US |
|
C
|
Cann Group Ltd
OTC:CNGGF
|
AU |
|
T
|
TX Group AG
XBER:TAMN
|
CH |
Wall St Price Targets
ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ACAD is 34.68 USD with a low forecast of 17.17 USD and a high forecast of 51.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ACAD's stock price target?
Price Target
34.68
USD
According to Wall Street analysts, the average 1-year price target for ACAD is 34.68 USD with a low forecast of 17.17 USD and a high forecast of 51.45 USD.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
33%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 33%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.
